Antibiotics are one of the most critical tools in a veterinarian’s toolbox because they cure bacterial diseases in animals. Without antibiotics, animals would suffer or even die at the hands of devastating diseases like pneumonia or anthrax. Antibiotics protect the welfare of animals. Living organisms produce antibiotics and work by killing harmful bacteria or limiting their growth and stopping illnesses from spreading. This prevents farm animals free from disease as well as allowing pets to live long and healthy lives. Antibiotics are used in food animals to treat clinical conditions, prevent and control common disease events, and enhance animal growth. Antibiotics can be used to treat a single animal with clinical illness or a large group of animals.
Antimicrobials have made an indelible contribution to animal health. Antimicrobials are extensively used in animals for disease control, treatment, and prevention and play an essential role as growth promoters in animal husbandry.
The global animal antibiotics and antimicrobials market size was valued at USD 4.3 billion in 2019 and projected to reach USD 5.80 billion by 2027, growing at a CAGR of 3.4% during the forecast period, 2020-2027. The major factors are the growing prevalence of zoonotic diseases and the implementation of regulations to prevent animal diseases. Additionally, the increasing initiatives concerning animal health and welfare will spur the global animal antibiotics and antimicrobials industry in the future periods. Furthermore, the growing livestock population and antimicrobials activities, and increasing animal disease outbreaks are expected to witness remarkable growth of animal antibiotics and antimicrobials. Furthermore, the growing demand for dairy products and growing end-use industries such animal meat industry are expected to propel the need for animal antibiotics and antimicrobials over the coming years.
Moreover, the upsurge in demand for animal-derived food products and the rise in consumption of meat or fish regularly are positively impacting the market for animal antibiotics and antimicrobials. Furthermore, the rapidly expanding animal healthcare spending and the growing demand for pet insurance are fueling the demand for animal antibiotics and antimicrobials market. Furthermore, animal companionship and a spike in demand for animal protein products will bolster global animal antibiotics and antimicrobials market share. Additionally, the growing incline towards pet adoption and increasing animal healthcare demands in the developing world propelling the growth of the animal antibiotics and antimicrobials market across the globe.
Owing to an increase in incomes, demand for higher food variety grows. As a result, demand for higher-value and quality foods such as milk, meat, and eggs rises, compared with food of plant origin such as cereals. These changes in consumption and sizeable population growth have led to significant increases in the total demand for animal Antibiotics and Antimicrobials Market. As per the Food and Agriculture Organization survey in 2018 on mapping, the supply and demand for animal-sourced food estimate that Asian countries will register the tremendous growth in the need for animal products such as mutton, pork, beef, milk, egg, and other poultry products. In addition, for dairy production, South Asia is one of the notable regions and accounted for 20–25% of the global milk production in 2019. India was the biggest producer and consumer of milk in this region, followed by China and Pakistan. In 2020, the consumption and demand for meat in India were over 3.9 million metric tons; by 2030, this will increase to 145.7 million metric tons. China has the largest share of meat consumption in the Asia Pacific. China has the largest share of meat consumption and consumes 28% of the world’s meat, including half of all pork. Thus, the overall consumption of animal-derived food products is predicted to boost Animal Antibiotics and Antimicrobials Market. Moreover, the meat & milk industries and livestock producers are increasingly utilizing animal health products to reduce the risk of zoonotic disease transmittance and maintain animal-derived food product quality.
The global animal antibiotics and antimicrobials market segregated into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobials and antibiotics. The tetracyclines segment is estimated to witness the highest growth over the analysis timeframe due to the higher efficiency of tetracycline. In addition, the advantages such as the highest potency against pathogenic microorganisms, low toxicity, and low cost compared to other animal antimicrobial and antibiotic products driving the market.
The penicillins will grow significantly due to the excellent tissue penetration and inexpensive compared to the other antibiotics.
Based on the mode of delivery, the global animal antibiotics and antimicrobials market is categorized into premixes, oral powder, oral solution, injection, and others. The premixes segment is held for a significant market share in 2019 and will gain maximum market revenue by 2027. It is attributable to the widespread advantages of premixes, such as a simplified model of administration, low cost, lower instability, and hygroscopicity of formulations.
The injection segment is poised to witness significant growth over the forecast period due to the immediate delivery of drugs and rapid onset of drug effects.
The global animal antibiotics and antimicrobials market is classified into food-producing animals and companion animals. Furthermore, the food animal segment is bifurcated into cattle, pigs, poultry, sheep and goats, and other food-producing animals. The companion animals segment is bifurcated into dogs, cats, horses, and other companion animals. The food-producing animals are expected to be the highest revenue share for animal antibiotics and antimicrobials during the forecast period. The segment’s hike is attributed to the growing demand for animal-derived food products, the rise in animal healthcare investment, and more significant concerns about zoonotic diseases.
The companion animals will witness a lucrative growth rate in the estimated period due to the increasing pet adoption and growing awareness about pet insurance policies.
The global animal antibiotics and antimicrobials market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America is estimated to project considerable growth over 2020-2026. It is owing to growth in pet insurance, rising demand for animal-derived food products, and rising animal health expenditure.
The Asia Pacific will have a prominent share of the animal antibiotics and antimicrobials market by 2027. It is due to the rapidly increasing animal population and soaring demand for animal-related products.
Companies such as Boehringer Ingelheim, Bayer AG, Ceva Sante Animale, Elanco Animal Health, Merck And Co. Inc., Novartis AG, Zoetis Inc., Vetoquinol, Virbac SA, Phibro Animal Health, Endovac Animal Health, Zydus, HIPRA, Dechra Pharmaceuticals Plc, Kyoritsu Seiyaku, Tianjin Ringpu, China Animal Husbandry, Indian Immunologicals Pvt. Ltd, UCBVET, American Reagent Inc., Neogen Corporation, Huvepharma Inc., Innovate, Lutim Pharma, ECO Animal Health, and Ayurvet are the key players in the global animal antibiotics and antimicrobials market.
By Type of Product
By Mode of Delivery
By Animal Type